DYNAVAX TECHNOLOGIES CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.73 USD | -2.54% |
|
-8.60% | -23.25% |
| May. 08 | Transcript : Dynavax Technologies Corporation, Q1 2024 Earnings Call, May 08, 2024 | |
| May. 08 | Earnings Flash (DVAX) DYNAVAX TECHNOLOGIES Posts Q1 Revenue $50.8M, vs. Street Est of $55M | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| DYNAVAX TECHNOLOGIES CORPORATION | Bio Therapeutic Drugs | -2.54% | -8.60% | -23.25% | -1.11% | +35.99% | 1.4B |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- DVAX Stock
- Charts Dynavax Technologies Corporation
- Comparison Chart